Free Trial

Moderna (MRNA) SEC Filings & 10K Form

$166.11
+2.10 (+1.28%)
(As of 03:52 PM ET)

Recent Moderna SEC Filings

DateFilerForm TypeView
05/22/2024
3:27 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
3:23 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2024
12:41 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2024
3:03 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
3:43 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2024
3:24 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2024
3:51 PM
LANGER ROBERT (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:54 PM
Horning Sandra (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:57 PM
Moderna (Issuer)
Tallett Elizabeth E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:59 PM
Moderna (Issuer)
SAGAN PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
4:02 PM
Moderna (Issuer)
Nader Francois (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:42 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
5:31 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
3:21 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/19/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
3:17 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2024
3:23 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
9:58 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/12/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:22 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
1:03 PM
Moderna (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
04/09/2024
3:09 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
2:32 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/05/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
3:20 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/29/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
3:22 PM
AFEYAN NOUBAR (Reporting)
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/22/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
7:46 AM
Moderna (Filer)
Form DEF 14A
03/21/2024
7:47 AM
Moderna (Filer)
Form DEFA14A
03/19/2024
3:39 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
11:12 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
8:30 AM
Moderna (Filer)
Form ARS
03/13/2024
3:24 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
8:05 AM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
2:22 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Who are Nvidia’s New Silent Partners? (Ad)

Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.

I call these Nvidia’s “Silent Partners.”
03/06/2024
2:13 PM
Garay Arpa (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
4:52 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
2:32 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
2:25 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:25 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:29 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:33 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:28 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:49 PM
Garay Arpa (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:32 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:37 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:39 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:24 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2024
3:21 PM
Moderna (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
2:39 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/22/2024
5:32 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
3:20 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
2:16 PM
Bancel Stephane (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
2:39 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2024
7:42 AM
Bancel Stephane (Filed by)
Moderna (Subject)
Form SC 13G/A
01/29/2024
2:26 PM
BlackRock Inc. (Filed by)
Moderna (Subject)
Form SC 13G/A
01/29/2024
9:49 AM
BAILLIE GIFFORD & CO (Filed by)
Moderna (Subject)
Form SC 13G/A
01/08/2024
2:21 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
6:03 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
7:00 AM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
10:37 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
7:04 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
2:24 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/07/2023
3:21 PM
Garay Arpa (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
2:13 PM
Garay Arpa (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
2:43 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
2:30 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2023
2:35 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2023
7:54 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
7:02 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
5:33 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/27/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
7:59 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
3:07 PM
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2023
3:07 PM
AFEYAN NOUBAR (Reporting)
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2023
3:51 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
6:02 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
2:17 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/29/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
3:38 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2023
3:06 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
6:28 PM
Bancel Stephane (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)

Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls.

Claim your free seat by clicking here now.
09/15/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
1:16 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:14 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
7:08 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2023
6:01 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2023
2:38 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
3:46 PM
Garay Arpa (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
3:17 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
2:22 PM
Garay Arpa (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MRNA) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners